These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34691056)

  • 21. Development of a Pan-H1 Influenza Vaccine.
    Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine.
    Yan J; Villarreal DO; Racine T; Chu JS; Walters JN; Morrow MP; Khan AS; Sardesai NY; Kim JJ; Kobinger GP; Weiner DB
    Vaccine; 2014 May; 32(24):2833-42. PubMed ID: 24631084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza.
    Werninghaus IC; Hinke DM; Fossum E; Bogen B; Braathen R
    Mol Ther; 2023 Jul; 31(7):2188-2205. PubMed ID: 36926694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
    Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
    Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
    Caillet C; Piras F; Bernard MC; de Montfort A; Boudet F; Vogel FR; Hoffenbach A; Moste C; Kusters I
    Vaccine; 2010 Apr; 28(18):3076-9. PubMed ID: 20193791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine.
    Yan J; Morrow MP; Chu JS; Racine T; Reed CC; Khan AS; Broderick KE; Kim JJ; Kobinger GP; Sardesai NY; Weiner DB
    Vaccine; 2018 May; 36(22):3079-3089. PubMed ID: 29100705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.
    Mooij P; Grødeland G; Koopman G; Andersen TK; Mortier D; Nieuwenhuis IG; Verschoor EJ; Fagrouch Z; Bogers WM; Bogen B
    Vaccine; 2019 Feb; 37(6):817-826. PubMed ID: 30638800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
    Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.
    Gorres JP; Lager KM; Kong WP; Royals M; Todd JP; Vincent AL; Wei CJ; Loving CL; Zanella EL; Janke B; Kehrli ME; Nabel GJ; Rao SS
    Clin Vaccine Immunol; 2011 Nov; 18(11):1987-95. PubMed ID: 21918118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
    Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.
    Shoji Y; Jones RM; Mett V; Chichester JA; Musiychuk K; Sun X; Tumpey TM; Green BJ; Shamloul M; Norikane J; Bi H; Hartman CE; Bottone C; Stewart M; Streatfield SJ; Yusibov V
    Hum Vaccin Immunother; 2013 Mar; 9(3):553-60. PubMed ID: 23296194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs.
    Grodeland G; Fossum E; Bogen B
    Vaccine; 2020 Feb; 38(6):1280-1285. PubMed ID: 31836256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.
    Baranowska M; Hauge AG; Hoornaert C; Bogen B; Grødeland G
    Vaccine; 2015 Dec; 33(49):6988-96. PubMed ID: 26387432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.
    Kodihalli S; Goto H; Kobasa DL; Krauss S; Kawaoka Y; Webster RG
    J Virol; 1999 Mar; 73(3):2094-8. PubMed ID: 9971791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene.
    Operschall E; Pavlovic J; Nawrath M; Mölling K
    Intervirology; 2000; 43(4-6):322-30. PubMed ID: 11251388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus.
    Hung JT; Tsai YC; Lin WD; Jan JT; Lin KH; Huang JR; Cheng JY; Chen MW; Wong CH; Yu AL
    Antiviral Res; 2014 Jul; 107():110-8. PubMed ID: 24786174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
    Tseng YC; Wu CY; Liu ML; Chen TH; Chiang WL; Yu YH; Jan JT; Lin KI; Wong CH; Ma C
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4200-4205. PubMed ID: 30782805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linear DNA vaccine prepared by large-scale PCR provides protective immunity against H1N1 influenza virus infection in mice.
    Wang F; Chen Q; Li S; Zhang C; Li S; Liu M; Mei K; Li C; Ma L; Yu X
    Vet Microbiol; 2017 Jun; 205():124-130. PubMed ID: 28622854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.